TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | -100.0% | 1,500 | -67.0% | 0.00% | -100.0% |
| Q4 2022 | $35 | -99.9% | 4,544 | -28.4% | 0.00% | +50.0% |
| Q3 2022 | $29,000 | – | 6,344 | +118.8% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 2,900 | -64.2% | 0.00% | -100.0% |
| Q1 2022 | $56,000 | +2700.0% | 8,100 | +376.5% | 0.00% | – |
| Q4 2021 | $2,000 | -71.4% | 1,700 | -55.4% | 0.00% | – |
| Q3 2021 | $7,000 | -82.1% | 3,810 | -17.4% | 0.00% | -100.0% |
| Q2 2021 | $39,000 | -43.5% | 4,610 | -69.9% | 0.00% | -33.3% |
| Q4 2020 | $69,000 | +1.5% | 15,300 | -6.1% | 0.00% | -25.0% |
| Q3 2020 | $68,000 | -10.5% | 16,300 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $76,000 | 0.0% | 16,300 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $76,000 | -70.1% | 16,300 | -65.5% | 0.00% | -75.0% |
| Q4 2019 | $254,000 | -12.7% | 47,202 | -0.4% | 0.02% | -40.7% |
| Q3 2019 | $291,000 | -42.4% | 47,402 | -19.8% | 0.03% | -42.6% |
| Q2 2019 | $505,000 | – | 59,091 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |